1. Home
  2. RGNX vs ASGI Comparison

RGNX vs ASGI Comparison

Compare RGNX & ASGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RGNX
  • ASGI
  • Stock Information
  • Founded
  • RGNX 2008
  • ASGI 2019
  • Country
  • RGNX United States
  • ASGI United States
  • Employees
  • RGNX N/A
  • ASGI N/A
  • Industry
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • ASGI Investment Managers
  • Sector
  • RGNX Health Care
  • ASGI Finance
  • Exchange
  • RGNX Nasdaq
  • ASGI Nasdaq
  • Market Cap
  • RGNX 459.1M
  • ASGI 472.4M
  • IPO Year
  • RGNX 2015
  • ASGI N/A
  • Fundamental
  • Price
  • RGNX $7.62
  • ASGI $17.71
  • Analyst Decision
  • RGNX Strong Buy
  • ASGI
  • Analyst Count
  • RGNX 12
  • ASGI 0
  • Target Price
  • RGNX $36.00
  • ASGI N/A
  • AVG Volume (30 Days)
  • RGNX 1.7M
  • ASGI 83.3K
  • Earning Date
  • RGNX 11-06-2024
  • ASGI 01-01-0001
  • Dividend Yield
  • RGNX N/A
  • ASGI 8.76%
  • EPS Growth
  • RGNX N/A
  • ASGI N/A
  • EPS
  • RGNX N/A
  • ASGI N/A
  • Revenue
  • RGNX $84,327,000.00
  • ASGI N/A
  • Revenue This Year
  • RGNX $2.34
  • ASGI N/A
  • Revenue Next Year
  • RGNX $243.67
  • ASGI N/A
  • P/E Ratio
  • RGNX N/A
  • ASGI N/A
  • Revenue Growth
  • RGNX N/A
  • ASGI N/A
  • 52 Week Low
  • RGNX $7.21
  • ASGI $14.96
  • 52 Week High
  • RGNX $28.80
  • ASGI $18.55
  • Technical
  • Relative Strength Index (RSI)
  • RGNX 36.08
  • ASGI 25.72
  • Support Level
  • RGNX $8.06
  • ASGI $17.33
  • Resistance Level
  • RGNX $10.52
  • ASGI $19.95
  • Average True Range (ATR)
  • RGNX 0.76
  • ASGI 0.32
  • MACD
  • RGNX -0.19
  • ASGI -0.21
  • Stochastic Oscillator
  • RGNX 12.39
  • ASGI 14.54

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

About ASGI abrdn Global Infrastructure Income Fund of Beneficial Interest

abrdn Global Infrastructure Income Fund is a non-diversified, closed-end management investment company. Its objective is to seek to provide a high level of total return with an emphasis on current income by investing in assets that provide necessary services to society.

Share on Social Networks: